相互に抵触する特許の英語

2006年には、TRIPS 理事会、WTO事務局次長主催の協議の場等において議論が行われたが、遺伝資源等の出所や原産国、遺伝資源等の利用にかかる事前の同意、及び公正かつ衡平な利益配分の証拠につき、特許出願中に開示を義務づけるため、TRIPS 協定を改正するよう求めるインド、ブラジル、ペルー等の諸国と、我が国、米国等、TRIPS 協定とCBD は抵触なく、相互補完的に履行可能であり、CBD の目的を達成するに当たってTRIPS 協定の改正は不要とする諸国との間に意見の隔たりが大きく、議論の収束には至っていない。例文帳に追加

In 2006, discussions were held at meetings of the TRIPS Council and under the auspices of the WTO Deputy Director-General. Some developing countries, such as India, Brazil and Peru, argue that the TRIPS Agreement should be amended to include a disclosure requirement of source and country of origin of genetic resources, prior informed consent to the use of genetic resources and provisions evidencing fair and equitable benefit sharing in order to obligate disclosure of such information in patent applications. To the contrary, Japan, the US and other countries find no conflict between the TRIPS Agreement and the CBD, and believe that it is possible to apply the two agreements in a mutually supportive manner. Therefore, there is a large gap between those countries that believe that amendment of the TRIPS Agreement is unnecessary in order to achieve the purpose of the CBD and those countries that believe it is necessary. Discussions have not converged yet. - 経済産業省